Tag - Drug Recall

Provider Alert!
02Feb

Provider Alert! Class I Drug Recall Notification: Zenzedi

Date: February 1, 2024 Attention: Providers Effective date: Immediately Call to action: On January 24, 2024, Azurity Pharmaceuticals voluntarily recalled one (1) lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg due to mislabeled packaging. ProductNDC No.Lot No.Exp. DateShip Dates toWholesalersZenzedi®(dextroamphetaminesulfate tablets, USP)30 mg24338-856-03F230169A2025-0608/23/2023 –11/29/2023 How this impacts providers: Patients who received this medication within the ship dates of 8/23/23-11/29/23 are required to return the medication and receive a replacement.  Next step for Providers: Providers should inform their impacted patients and arrange for the...

By OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , 0 CommentsRead more...
06Jan

Zantac/ranitidine drug recalls due to NDMA impurity

Multiple drug manufacturers have issued voluntary drug recalls for several Zantac drug products and its generic, ranitidine. Ranitidine is a histamine-2 receptor antagonist used to treat heartburn and related conditions. Potentially impacted customers are being notified with a recommendation to stop taking the medication and to discuss alternative therapies with their provider. The recalls are due to discovery of an impurity (N-nitrosodimethylamine [NDMA]) in the finished product. NDMA is classified as a probable human carcinogen that may be found in certain...

By OB/GYNs, Primary Care Providers, Specialists, , , 0 CommentsRead more...